As of Aug 18
| +0.28 / +0.38%|
The 15 analysts offering 12-month price forecasts for ResMed Inc have a median target of 76.05, with a high estimate of 84.75 and a low estimate of 55.00. The median estimate represents a +4.08% increase from the last price of 73.07.
The current consensus among 19 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since August, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.